Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-01

FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lovastatin from Carlsbad Technology, Inc., expanding access to a generic statin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovastatin (Lovastatin)

Snippet

SUPPL AP for LOVASTATIN (LOVASTATIN)